Literature DB >> 24253855

Low-carbohydrate diet versus euglycemic hyperinsulinemic clamp for the assessment of myocardial viability with 18F-fluorodeoxyglucose-PET: a pilot study.

José Soares1, Filadelfo Rodrigues Filho, Marisa Izaki, Maria Clementina P Giorgi, Rosa M A Catapirra, Rubens Abe, Carmen G C M Vinagre, Giovanni G Cerri, José Cláudio Meneghetti.   

Abstract

Positron emission tomography with (18)F-fluorodeoxyglucose (FDG-PET) is considered the gold standard for myocardial viability. A pilot study was undertaken to compare FDG-PET using euglycemic hyperinsulinemic clamp before (18)F-fluorodeoxyglucose ((18)F-FDG) administration (PET-CLAMP) with a new proposed technique consisting of a 24-h low-carbohydrate diet before (18)F-FDG injection (PET-DIET), for the assessment of hypoperfused but viable myocardium (hibernating myocardium). Thirty patients with previous myocardial infarction were subjected to rest (99m)Tc-sestamibi-SPECT and two (18)F-FDG studies (PET-CLAMP and PET-DIET). Myocardial tracer uptake was visually scored using a 5-point scale in a 17-segment model. Hibernating myocardium was defined as normal or mildly reduced metabolism ((18)F-FDG uptake) in areas with reduced perfusion ((99m)Tc-sestamibi uptake) since (18)F-FDG uptake was higher than the degree of hypoperfusion-perfusion/metabolism mismatch indicating a larger flow defect. PET-DIET identified 79 segments and PET-CLAMP 71 as hibernating myocardium. Both methods agreed in 61 segments (agreement = 94.5 %, κ = 0.78). PET-DIET identified 230 segments and PET-CLAMP 238 as nonviable. None of the patients had hypoglycemia after DIET, while 20 % had it during CLAMP. PET-DIET compared with PET-CLAMP had a good correlation for the assessment of hibernating myocardium. To our knowledge, these data provide the first evidence of the possibility of myocardial viability assessment with this technique.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24253855     DOI: 10.1007/s10554-013-0324-5

Source DB:  PubMed          Journal:  Int J Cardiovasc Imaging        ISSN: 1569-5794            Impact factor:   2.357


  44 in total

1.  Assessment of myocardial viability with contrast-enhanced magnetic resonance imaging: comparison with positron emission tomography.

Authors:  Christoph Klein; Stephan G Nekolla; Frank M Bengel; Mitsuru Momose; Andrea Sammer; Felix Haas; Bernhard Schnackenburg; Wolfram Delius; Harald Mudra; Dieter Wolfram; Markus Schwaiger
Journal:  Circulation       Date:  2002-01-15       Impact factor: 29.690

Review 2.  Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association.

Authors:  Manuel D Cerqueira; Neil J Weissman; Vasken Dilsizian; Alice K Jacobs; Sanjiv Kaul; Warren K Laskey; Dudley J Pennell; John A Rumberger; Thomas Ryan; Mario S Verani
Journal:  Circulation       Date:  2002-01-29       Impact factor: 29.690

Review 3.  The kappa statistic in reliability studies: use, interpretation, and sample size requirements.

Authors:  Julius Sim; Chris C Wright
Journal:  Phys Ther       Date:  2005-03

Review 4.  [Myocardial viability, its importance for the therapeutic decision].

Authors:  Erick Alexánderson; Alejandro Ricalde; Aloha Meave
Journal:  Arch Cardiol Mex       Date:  2005 Jan-Mar

5.  Optimal metabolic conditions during fluorine-18 fluorodeoxyglucose imaging; a comparative study using different protocols.

Authors:  J J Bax; M A Veening; F C Visser; A van Lingen; R J Heine; J H Cornel; C A Visser
Journal:  Eur J Nucl Med       Date:  1997-01

6.  Added value of attenuation-corrected Tc-99m tetrofosmin SPECT for the detection of myocardial viability: comparison with FDG SPECT.

Authors:  Riemer H J A Slart; Jeroen J Bax; Wim J Sluiter; Dirk J van Veldhuisen; Pieter L Jager
Journal:  J Nucl Cardiol       Date:  2004 Nov-Dec       Impact factor: 5.952

7.  Direct comparison of fluorine-18-FDG SPECT, fluorine-18-FDG PET and rest thallium-201 SPECT for detection of myocardial viability.

Authors:  R W Burt; O W Perkins; B E Oppenheim; D S Schauwecker; L Stein; H N Wellman; R M Witt
Journal:  J Nucl Med       Date:  1995-02       Impact factor: 10.057

Review 8.  Assessment of myocardial viability in patients with heart failure.

Authors:  Arend F L Schinkel; Don Poldermans; Abdou Elhendy; Jeroen J Bax
Journal:  J Nucl Med       Date:  2007-06-15       Impact factor: 10.057

9.  Suppression of myocardial 18F-FDG uptake by preparing patients with a high-fat, low-carbohydrate diet.

Authors:  Gethin Williams; Gerald M Kolodny
Journal:  AJR Am J Roentgenol       Date:  2008-02       Impact factor: 3.959

Review 10.  Stunning, hibernation, and assessment of myocardial viability.

Authors:  Paolo G Camici; Sanjay Kumak Prasad; Ornella E Rimoldi
Journal:  Circulation       Date:  2008-01-01       Impact factor: 29.690

View more
  3 in total

Review 1.  Cardiovascular imaging 2014 in the International Journal of Cardiovascular Imaging.

Authors: 
Journal:  Int J Cardiovasc Imaging       Date:  2015-03       Impact factor: 2.357

2.  Status of F-18 fluorodeoxyglucose uptake in normal and hibernating myocardium after glucose and insulin loading.

Authors:  Ismet Sarikaya; A H Elgazzar; M A Alfeeli; P N Sharma; A Sarikaya
Journal:  J Saudi Heart Assoc       Date:  2017-07-10

3.  Assessing oral glucose and intravenous insulin loading protocol in 18F-fluorodeoxyglucose positron emission tomography cardiac viability studies.

Authors:  Ismet Sarikaya; Prem N Sharma; Ali Sarikaya; Abdelhamid H Elgazzar
Journal:  World J Nucl Med       Date:  2020-02-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.